EXHIBIT A
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Viridian Therapeutics, Inc.
Date: August 26, 2021 | Frazier Life Sciences Public Fund L.P. | |||||
By: | FHMLSP, L.P., its General Partner | |||||
By: | FHMLSP, L.L.C., its General Partner | |||||
By: | /s/ Steve R. Bailey | |||||
Steve R. Bailey, Chief Financial Officer | ||||||
Date: August 26, 2021 | FHMLSP, .L.P. | |||||
By: | FHMLSP, L.L.C., its General Partner | |||||
By: | /s/ Steve R. Bailey | |||||
Steve R. Bailey, Chief Financial Officer | ||||||
Date: August 26, 2021 | FHMLSP, L.L.C. | |||||
By: | /s/ Steve R. Bailey | |||||
Steve R. Bailey, Chief Financial Officer | ||||||
Date: August 26, 2021 | By: | * | ||||
James N. Topper | ||||||
Date: August 26, 2021 | By: | * | ||||
Patrick J. Heron | ||||||
Date: August 26, 2021 | By: | ** | ||||
Albert Cha | ||||||
Date: August 26, 2021 | By: | ** | ||||
James Brush | ||||||
Date: August 26, 2021 | By: | /s/ Steve R. Bailey | ||||
Steve R. Bailey, as Attorney-in-Fact |
* | This Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on February 24, 2017. |
** | This Agreement was executed by Steve R. Bailey on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021. |